Mitokinin
San Francisco
About Mitokinin
Mitokinin is operates in the healthcare industry focusing on biotechnology business. It launches medicinal chemistry effort to generate kinetin analogs optimized for activating PINK1. It plans to develop the analog or optimized variants to treat Parkinson's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2018)
- Website: mitokinin.com
- Phone: (347) 668-8061
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mitokinin-35456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.